CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C17104 | BRD-K46068882 | eugenitol | -- | -- | -- | Details |
| C17105 | BRD-K46074482 | BRD-K46074482 | -- | -- | -- | Details |
| C17106 | BRD-K46080444 | BRD-K46080444 | -- | -- | -- | Details |
| C17107 | BRD-K46082587 | BRD-K46082587 | -- | -- | -- | Details |
| C17108 | BRD-K46082763 | BRD-K46082763 | -- | -- | -- | Details |
| C17109 | BRD-K46085646 | BRD-K46085646 | -- | -- | -- | Details |
| C17110 | BRD-K46088987 | BRD-K46088987 | -- | -- | -- | Details |
| C17111 | BRD-K46092809 | BRD-K46092809 | -- | -- | -- | Details |
| C17112 | BRD-K46095779 | BRD-K46095779 | -- | -- | -- | Details |
| C17113 | BRD-K46096244 | BRD-K46096244 | -- | -- | -- | Details |
| C17114 | BRD-K46098747 | BRD-K46098747 | -- | -- | -- | Details |
| C17115 | BRD-K46107062 | BRD-K46107062 | -- | -- | -- | Details |
| C17116 | BRD-K46118045 | BRD-K46118045 | -- | -- | -- | Details |
| C17117 | BRD-K46119789 | BRD-K46119789 | -- | -- | -- | Details |
| C17118 | BRD-K46120075 | BRD-K46120075 | -- | -- | -- | Details |
| C17119 | BRD-K46120925 | BRD-K46120925 | -- | -- | -- | Details |
| C17120 | BRD-K46121327 | BRD-K46121327 | -- | -- | -- | Details |
| C17121 | BRD-K46123637 | BRD-K46123637 | -- | -- | -- | Details |
| C17122 | BRD-K46124507 | BRD-K46124507 | -- | -- | -- | Details |
| C17123 | BRD-K46126513 | BRD-K46126513 | -- | -- | -- | Details |
| C17124 | BRD-K46133855 | NXY-059 | -- | -- | -- | Details |
| C17125 | BRD-K46137903 | prednicarbate | NR3C1 | Phospholipase activator | -- | Details |
| C17126 | BRD-K46141002 | BRD-K46141002 | -- | -- | -- | Details |
| C17127 | BRD-K46142322 | RS-67333 | HTR4 | Serotonin receptor partial agonist | -- | Details |
| C17128 | BRD-K46149271 | BRD-K46149271 | -- | -- | -- | Details |
| C17129 | BRD-K46149455 | BRD-K46149455 | -- | -- | -- | Details |
| C17130 | BRD-K46152990 | BRD-K46152990 | -- | -- | -- | Details |
| C17131 | BRD-K46155530 | BRD-K46155530 | -- | -- | -- | Details |
| C17132 | BRD-K46155894 | BRD-K46155894 | -- | -- | -- | Details |
| C17133 | BRD-K46156294 | tyloxapol | -- | -- | -- | Details |
| C17134 | BRD-K46161579 | BRD-K46161579 | -- | -- | -- | Details |
| C17135 | BRD-K46162352 | BRD-K46162352 | -- | -- | -- | Details |
| C17136 | BRD-K46170844 | BRD-K46170844 | -- | -- | -- | Details |
| C17137 | BRD-K46171140 | BRD-K46171140 | -- | -- | -- | Details |
| C17138 | BRD-K46171293 | BRD-K46171293 | -- | -- | -- | Details |
| C17139 | BRD-K46171503 | BRD-K46171503 | -- | -- | -- | Details |
| C17140 | BRD-K46176518 | BRD-K46176518 | -- | -- | -- | Details |
| C17141 | BRD-K46178029 | BRD-K46178029 | -- | -- | -- | Details |
| C17142 | BRD-K46183911 | BRD-K46183911 | -- | -- | -- | Details |
| C17143 | BRD-K46184370 | BRD-K46184370 | -- | -- | -- | Details |
| C17144 | BRD-K46185480 | BRD-K46185480 | -- | -- | -- | Details |
| C17145 | BRD-K46192888 | BRD-K46192888 | -- | -- | -- | Details |
| C17146 | BRD-K46195730 | BRD-K46195730 | -- | -- | -- | Details |
| C17147 | BRD-K46205969 | BRD-K46205969 | -- | -- | -- | Details |
| C17148 | BRD-K46206861 | BRD-K46206861 | -- | -- | -- | Details |
| C17149 | BRD-K46209126 | pravadoline | -- | -- | -- | Details |
| C17150 | BRD-K46211110 | BRD-K46211110 | -- | -- | -- | Details |
| C17151 | BRD-K46211610 | tolazoline | ADRA2A; ADRA2B; ADRA2C | Adrenergic receptor antagonist | -- | Details |
| C17152 | BRD-K46212057 | voriconazole | CYP2C19; CYP2C9; CYP3A4; CYP3A5; PTGS1 | Cytochrome P450 inhibitor | -- | Details |
| C17153 | BRD-K46232974 | BRD-K46232974 | -- | -- | -- | Details |
| C17154 | BRD-K46239287 | BRD-K46239287 | -- | -- | -- | Details |
| C17155 | BRD-K46239950 | BRD-K46239950 | -- | -- | -- | Details |
| C17156 | BRD-K46241566 | BRD-K46241566 | -- | -- | -- | Details |
| C17157 | BRD-K46242161 | BRD-K46242161 | -- | -- | -- | Details |
| C17158 | BRD-K46255436 | SA-1463787 | -- | -- | -- | Details |
| C17159 | BRD-K46255814 | BRD-K46255814 | -- | -- | -- | Details |
| C17160 | BRD-K46261417 | BRD-K46261417 | -- | -- | -- | Details |
| C17161 | BRD-K46267071 | BRD-K46267071 | -- | -- | -- | Details |
| C17162 | BRD-K46268437 | BRD-K46268437 | -- | -- | -- | Details |
| C17163 | BRD-K46269666 | BRD-K46269666 | -- | -- | -- | Details |
| C17164 | BRD-K46272620 | valyltryptophan | -- | -- | -- | Details |
| C17165 | BRD-K46273627 | BRD-K46273627 | -- | -- | -- | Details |
| C17166 | BRD-K46276961 | BRD-K46276961 | -- | -- | -- | Details |
| C17167 | BRD-K46284961 | BRD-K46284961 | -- | -- | -- | Details |
| C17168 | BRD-K46285453 | BRD-K46285453 | -- | -- | -- | Details |
| C17169 | BRD-K46290096 | preladenant | ADORA2A | Adenosine receptor antagonist | -- | Details |
| C17170 | BRD-K46291400 | BRD-K46291400 | -- | -- | -- | Details |
| C17171 | BRD-K46293468 | BRD-K46293468 | -- | -- | -- | Details |
| C17172 | BRD-K46295497 | BRD-K46295497 | -- | -- | -- | Details |
| C17173 | BRD-K46297593 | BRD-K46297593 | -- | -- | -- | Details |
| C17174 | BRD-K46298074 | BRD-K46298074 | -- | -- | -- | Details |
| C17175 | BRD-K46298577 | BRD-K46298577 | -- | -- | -- | Details |
| C17176 | BRD-K46298622 | BRD-K46298622 | -- | -- | -- | Details |
| C17177 | BRD-K46300014 | BRD-K46300014 | -- | -- | -- | Details |
| C17178 | BRD-K46306128 | BRD-K46306128 | -- | -- | -- | Details |
| C17179 | BRD-K46306993 | BRD-K46306993 | -- | -- | -- | Details |
| C17180 | BRD-K46308702 | BRD-K46308702 | -- | -- | -- | Details |
| C17181 | BRD-K46311453 | BRD-K46311453 | -- | -- | -- | Details |
| C17182 | BRD-K46313713 | BRD-K46313713 | -- | -- | -- | Details |
| C17183 | BRD-K46317332 | proadifen | NOS1 | Nitric oxide synthase inhibitor | -- | Details |
| C17184 | BRD-K46319090 | BRD-K46319090 | -- | -- | -- | Details |
| C17185 | BRD-K46322281 | BRD-K46322281 | -- | -- | -- | Details |
| C17186 | BRD-K46322935 | BRD-K46322935 | -- | -- | -- | Details |
| C17187 | BRD-K46334103 | BRD-K46334103 | -- | -- | -- | Details |
| C17188 | BRD-K46343228 | BRD-K46343228 | -- | -- | -- | Details |
| C17189 | BRD-K46348476 | BRD-K46348476 | -- | -- | -- | Details |
| C17190 | BRD-K46352899 | BRD-K46352899 | -- | -- | -- | Details |
| C17191 | BRD-K46359800 | BRD-K46359800 | -- | -- | -- | Details |
| C17192 | BRD-K46362951 | BRD-K46362951 | -- | -- | -- | Details |
| C17193 | BRD-K46363727 | BRD-K46363727 | -- | -- | -- | Details |
| C17194 | BRD-K46370825 | BRD-K46370825 | -- | -- | -- | Details |
| C17195 | BRD-K46373671 | BRD-K46373671 | -- | -- | -- | Details |
| C17196 | BRD-K46373821 | BRD-K46373821 | -- | -- | -- | Details |
| C17197 | BRD-K46376359 | BRD-K46376359 | -- | -- | -- | Details |
| C17198 | BRD-K46378421 | BRD-K46378421 | -- | -- | -- | Details |
| C17199 | BRD-K46381939 | BRD-K46381939 | -- | -- | -- | Details |
| C17200 | BRD-K46384212 | O-3M3FBS | -- | -- | -- | Details |
| C17201 | BRD-K46384573 | BRD-K46384573 | -- | -- | -- | Details |
| C17202 | BRD-K46385262 | BRD-K46385262 | -- | -- | -- | Details |
| C17203 | BRD-K46386702 | ARRY-334543 | EGFR; ERBB2 | EGFR inhibitor | -- | Details |